Antonio G.
- Country
- Italy
- Department
- Unità Operativa Complessa Medicina Interna e Gastroenterologia
Research Overview
- A randomized, double-blind, placebo controlled, dose finding study to assess the efficacy and safety of SAR443122 in adult patients with moderate to severe ulcerative colitis
- Long-term Safety, Tolerability, and Efficacy of Balinatunfib in Adults with Crohn's Disease or Ulcerative Colitis: A Multicenter Extension Study
- Phase II Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Vixarelimab in Patients with Moderate to Severe Ulcerative Colitis
Data & Insights
Has run more than one trial at 579 of 865 partner sites.
Specializations
Inflammatory Bowel Disease
This investigator specializes in treating inflammatory bowel conditions, with particular emphasis on ulcerative colitis and Crohn's disease. Their research encompasses various therapeutic approaches for moderate to severe cases.
- Ulcerative Colitis Management
- Fibrostenotic Crohn's Disease
- Short Bowel Syndrome
The investigator explores novel treatment options including biologics and small molecule therapies for inflammatory bowel conditions.
Hepatic Disorders
The investigator focuses on treating various liver conditions, particularly hepatocellular carcinoma and metabolic dysfunction-associated steatohepatitis.
- Advanced Liver Cancer Treatment
- MASH with Compensated Cirrhosis
- Post-Resection Cancer Care
Their work includes investigating immunotherapy approaches and combination treatments for liver disorders.
Gastrointestinal Disorders
The investigator studies various gastrointestinal conditions, with specific attention to eosinophilic esophagitis and related inflammatory disorders.
- Esophageal Inflammation
- Immune-Mediated GI Conditions
- Therapeutic Innovation
Their research extends to both adult and adolescent patients with gastrointestinal inflammatory conditions.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.